| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5700131 | Clinical Oncology | 2007 | 4 Pages |
Abstract
The combination of gemcitabine and 13-cis-RA was well tolerated, but we did not see improvement in the response rate. Further studies with other retinoids may be beneficial to patients with unresectable pancreatic cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A. Michael, M. Hill, A. Maraveyas, A. Dalgleish, F. Lofts,